Feng Jin

机构：Guiyang Medical University, Affiliated Hospital of Guizhou Medical University, Wuhan Union Hospital, Union Hospital · ORCID：0000-0002-1092-8086

发表论文 104 篇 · 总被引 3524 次 · h-index 22

代表论文

• Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma (2023 · JAMA · 被引 254)
• Nivolumab combined with induction chemotherapy and radiotherapy in nasopharyngeal carcinoma: A multicenter phase 2 PLATINUM trial (2025 · Cancer Cell · 被引 40)
• Toripalimab Combination Therapy Without Concurrent Cisplatin for Nasopharyngeal Carcinoma (2025 · JAMA · 被引 29)
• Efficacy and safety of cadonilimab in previously treated recurrent or metastatic nasopharyngeal carcinoma(COMPASSION-06): A phase II multicenter study (2024 · Oral Oncology · 被引 26)
• PD-1 blockade with sintilimab plus induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) versus IC-CCRT in locoregionally-advanced nasopharyngeal carcinoma (LANPC): A multicenter, phase 3, randomized controlled trial (CONTINUUM). (2023 · Journal of Clinical Oncology · 被引 19)
• Adjuvant PD-1 blockade with camrelizumab in high-risk locoregionally advanced nasopharyngeal carcinoma (DIPPER): A multicenter, open-label, phase 3, randomized controlled trial. (2024 · Journal of Clinical Oncology · 被引 17)